Risk of Neonatal Drug Withdrawal After Intrauterine Co-Exposure to Opioids and Psychotropics

< Back to All Resources

This study from the BMJ analyzes the effects of opioid and psychotropic medications during pregnancy in relation to risk of neonatal drug withdrawals. Within the United States about 14-22% of pregnancies are complicated due to the use of prescription opioid medications – resulting in an infant being born every 25 minutes with signs of opioid withdrawal. Researchers concluded that despite a lack of safety data, use of prescription opioids and psychotropic medications is common during pregnancy. However, study findings showed a 30-60% increase in the risk of neonatal drug withdrawal associatted with co-exposure to prescription opioids and antidepressants, benzodiazepines, and gabapentin.


Related Topics

  • Behavioral Health
  • Child Welfare
  • Children 0-5
  • Medications for Addiction Treatment (MAT)
  • Medical Care
  • Neonatal Abstinence Syndrome (NAS)